Glaxo Eyes Human Genome Sciences for $2.6 Billion
16 Luglio 2012 - 1:10AM
Dow Jones News
GlaxoSmithKline PLC (GSK, GSK.LN) is in talks to acquire Human
Genome Sciences Inc. (HGSI) in a $2.6 billion deal, Reuters reports
on its website Sunday, citing "sources familiar with the
situation."
Citing one of the sources, Reuters reported that GlaxoSmithKline
could sweeten the deal slightly, and that an announcement could
come as early as Monday.
A spokesman from GlaxoSmithKline declined to comment, Reuters
said, adding Human Genome Sciences officials were not immediately
available.
Full story at
http://www.reuters.com/article/2012/07/15/us-humangenome-glaxosmithkline-idUSBRE8
E08P20120715
-Write to copydesk@dowjones.com
Grafico Azioni Human Genome Sciences (NASDAQ:HGSI)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Human Genome Sciences (NASDAQ:HGSI)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Human Genome Sciences, Inc. (MM) (NASDAQ): 0 articoli recenti
Più Human Genome Sciences Inc. Articoli Notizie